Planning GMP Cleanrooms: Requirements, Standards, and Best Practices

Whether it’s tablets, vaccines, or modern biotech therapies—wherever pharmaceuticals are produced, the manufacturing environment is a critical factor. Good Manufacturing Practice (GMP) requires that products not only be effective and safe but also be manufactured under strictly controlled conditions.

Cleanrooms are at the heart of pharmaceutical and biotechnology production: They create the controlled environment that minimizes cross-contamination and particle contamination—and thus lay the foundation for patient safety and regulatory compliance. In this article, we provide a step-by-step guide to the applicable requirements, how cleanroom classes (GMP A–D / ISO 14644) work, and how to plan, build, qualify, and operate GMP cleanrooms—including typical best practices.

Read more here

Regulatory Requirements and Inspection Expectations for Cleanrooms

Cleanrooms are subject to a clear, internationally harmonized set of regulations. Key requirements include:

  • EU GMP Guidelines (Annex 1: Manufacture of Sterile Products)
  • ISO 14644 (Parts 1–3: Classification and Test Methods)
  • FDA cGMP (21 CFR 210/211) for the U.S. market
  • WHO GMP and PIC/S for international markets

Regulatory agencies such as the EMA, FDA, or national inspectorates pay particular attention during inspections to:

  • Correct classification of cleanroom classes
  • Traceability of airflow patterns, pressure levels, and hygiene concepts
  • Complete documentation (monitoring, deviations, CAPA)

Practical Note: Many findings during GMP inspections do not relate to the technology itself, but rather to a lack of documentation or unclear interfaces between planning, operations, and quality assurance.

Cleanroom Classes and Applications

What is a cleanroom class?
Cleanroom classes are defined levels of cleanliness for controlled environments. They specify which particle concentrations (per m³ of air—depending on particle size) and—in the context of GMP for sterile manufacturing—which microbiological requirements are permissible in a given area. Technically, the classification is based on ISO 14644-1; for sterile pharmaceuticals, EU GMP Annex 1 describes Grades A–D. Both systems serve different purposes and are not directly interchangeable—correspondence is only possible to a limited extent.

Operating conditions according to ISO 14644:

  • as-built (empty, without personnel or production)
  • at-rest (installed, with equipment, without personnel)
  • in-operation (under actual operating conditions)

Key point: GMP grades define the hygienic environment specifically for sterile pharmaceutical processes, while ISO 14644 classifies the particle-based cleanliness of rooms. Combining both perspectives leads to the correct selection of the cleanroom class for each process step.

An Overview of Cleanroom Classes

GMP Class Typical Application Approximately Equivalent to ISO Class Airflow
A Aseptic operations, filling, open sterile products ISO ~4.8 unidirectional (laminar)
B Background for Class A (e.g., aseptic manufacturing) ISO ~5 turbulent / partially unidirectional
C Less critical sterile steps (e.g., formulation prior to sterile filtration) ISO ~7 turbulent
D Preparatory/non-critical production steps ISO ~8 turbulent

Cleanroom Design

Planning is the most critical step—errors in planning can only be corrected later with immense effort and at great cost.

Key planning principles:

  • Site restrictions: available space, utility connections, regulatory framework
  • Zone and airlock concepts: clear separation of pedestrian and material routes, defined pressure levels
  • Personnel and material flow: as unidirectional as possible, without crossings, to minimize contamination risks
  • Technical room specifications: detailed description of all rooms, functions, and parameters (including temperature, humidity, and air change rates)
  • Digital planning tools (BIM): facilitate coordination between architecture, HVAC, process engineering, and IT

Key point: A cleanroom is only as good as its weakest link—a poorly planned airlock and material flow concept can negate even the best filtration technology.

Construction of Cleanrooms

When it comes to construction, the details matter—and these are often scrutinized during audits:

  • Walls and ceilings: smooth, seamless surfaces that are easy to clean and resistant to disinfectants
  • Floors: seamless, slip-resistant, resistant to chemicals
  • Doors and windows: airtight, automatic closing mechanisms, viewing windows for process monitoring
  • Isolators and RABS: are increasingly used to isolate particularly critical processes from the environment and ensure product safety
  • Pressure-tier concepts: ensure that air always flows from clean areas to less clean areas

Qualification and Validation of Cleanrooms

Cleanrooms must be qualified before commissioning and on a regular basis during operation. This is done in four steps:

  1. DQ – Design Qualification (design in accordance with specifications)
  2. IQ – Installation Qualification (correct installation)
  3. OQ – Operational Qualification (function under operating conditions)
  4. PQ – Performance Qualification (performance in the actual process)

Typical tests:

  • Particle measurements (air, surfaces)
  • Microbiological testing
  • Pressure differential and airflow tests

Important: Any change (modification, new equipment, new airlock) is subject to change control and must be documented and evaluated.

Operation of Cleanrooms

A cleanroom is not a static project—it thrives on consistent operation.

Key elements:

  • Monitoring: continuous measurement of particle counts, microorganisms, temperature, humidity, and pressure
  • Cleaning and maintenance: validated procedures, clear SOPs, regular disinfection
  • Hygiene protocols: clothing regulations, personal hygiene, access control
  • Training: regular training sessions, preparation for inspections, awareness of deviations
  • Emergency and Alarm Management: e.g., in the event of a pressure drop or particle count exceedance
  • Lifecycle management: Cleanrooms must be operated in compliance with GMP, documented, and regularly requalified over the course of many years

Best Practices and Common Sources of Errors in Cleanrooms

  • Faulty interfaces: e.g., unclear transitions between production and the warehouse
  • Incorrect pressure-level concepts: lead to backflow of contaminated air or cross-contamination
  • Underestimated human factors: People are the largest source of particles—training and discipline are crucial
  • The cost trap of overengineering: overly complex technology can be difficult to maintain later on

Best Practice: Early, interdisciplinary planning (architects, process engineers, GMP experts, operators) saves costs in the long term and prevents retrofits.

Conclusion and Outlook

Cleanrooms are more than just sterile rooms—they are highly complex systems that form the backbone of pharmaceutical and biotechnology production. Those who design, build, and operate GMP-compliant cleanrooms lay the foundation for safe medicines, regulatory compliance, and long-term competitiveness.

Future Trends:

  • Digitalization and automation (e.g., IoT sensors, AI-supported monitoring)
  • Sustainable cleanroom solutions (energy efficiency, modular systems)
  • Flexibility through modular design for faster adaptation to new products

Cleanroom Expertise with io

The planning and implementation of GMP cleanrooms require experience at the intersection of technology, regulations, and processes.
For years, io has been supporting pharmaceutical and biotech companies in:

  • the planning of GMP-compliant cleanroom concepts
  • the integration of modern HVAC and monitoring systems
  • qualification and validation in accordance with EU GMP and ISO 14644
  • as well as coordinating the interfaces between construction, process engineering, and quality management

This results in customized solutions that are not only regulatory-compliant but also efficient and future-proof—helping companies bring their products to market faster and more safely.

Read more articles on GMP

We'll guide you every step of the way, from the initial idea to an audit-ready installation

Contact our expert for a structured assessment of your project.

Your contact person
Hans-Jürgen Budde Senior Business Unit Manager Pharma
Hans-Jürgen Budde
Senior Business Unit Manager Life Sciences